|
1
|
Sadaka A, Sisk RA, Osher JM, Toygar O,
Duncan MK and Riemann CD: Intravitreal methotrexate infusion for
proliferative vitreoretinopathy. Clin Ophthalmol. 10:1811–1817.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Claes C and Lafetá AP: Proliferative
vitreoretinopathy. Dev Ophthalmol. 54:188–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pena RA, Jerdan JA and Glaser BM: Effects
of TGF-beta and TGF-beta neutralizing antibodies on
fibroblast-induced collagen gel contraction: Implications for
proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci.
35:2804–2808. 1994.PubMed/NCBI
|
|
4
|
Lappin DW, McMahon R, Murphy M and Brady
HR: Gremlin: An example of the re-emergence of developmental
programmes in diabetic nephropathy. Nephrol Dial Transplant. 17
(Suppl 9):S65–S67. 2002. View Article : Google Scholar
|
|
5
|
Grillo E, Ravelli C, Corsini M,
Ballmer-Hofer K, Zammataro L, Oreste P, Zoppetti G, Tobia C, Ronca
R, Presta M and Mitola S: Monomeric gremlin is a novel vascular
endothelial growth factor receptor-2 antagonist. Oncotarget.
7:35353–35368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kišonaitė M, Wang X and Hyvönen M:
Structure of Gremlin-1 and analysis of its interaction with BMP-2.
Biochem J. 473:1593–1604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin Y, Yang Y, Yang L, Yang Y, Li C, Liu X
and Qu Y: Overexpression of Gremlin promotes non-small cell lung
cancer progression. Tumour Biol. 37:2597–2602. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wordinger RJ, Zode G and Clark AF: Focus
on molecules: Gremlin. Exp Eye Res. 87:78–79. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Müller I, Schönberger T, Schneider M,
Borst O, Ziegler M, Seizer P, Leder C, Müller K, Lang M,
Appenzeller F, et al: Gremlin-1 is an inhibitor of macrophage
migration inhibitory factor and attenuates atherosclerotic plaque
growth in ApoE−/− Mice. J Biol Chem. 288:31635–31645.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sethi A, Wordinger RJ and Clark AF:
Gremlin utilizes canonical and non-canonical TGFb signaling to
induce lysyl oxidase (LOX) genes in human trabecular meshwork
cells. Exp Eye Res. 113:117–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cahill E, Costello CM, Rowan SC, Harkin S,
Howell K, Leonard MO, Southwood M, Cummins EP, Fitzpatrick SF,
Taylor CT, et al: Gremlin plays a key role in the pathogenesis of
pulmonary hypertension. Circulation. 125:920–930. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitola S, Ravelli C, Moroni E, Salvi V,
Leali D, BallmerHofer K, Zammataro L and Presta M: Gremlin is a
novel agonist of the major proangiogenic receptor VEGFR2. Blood.
116:3677–3680. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kane R, Stevenson L, Godson C, Stitt AW
and O'Brien CO: Gremlin gene expression in bovine retinal pericytes
exposed to elevated glucose. Br J Ophthalmol. 89:1638–1642. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McMahon R, Murphy M, Clarkson M, Taal M,
Mackenzie HS, Godson C, Martin F and Brady HR: IHG-2, a mesangial
cell gene induced by high glucose, is human gremlin. Regulation by
extracellular glucose concentration, cyclic mechanical strain, and
transforming growth factor-beta 1. J Biol Chem. 275:9901–9904.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee H, O'Meara SJ, O'Brien C and Kane R:
The role of Gremlin, a BMP antagonist, and
epithelial-to-mesenchymal transition in proliferative
vitreoretinopathy. Invest Ophthalmol Vis Sci. 48:4291–4299. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen J, Ma Y, Wang Z, Wang H, Wang L, Xiao
F, Wang H, Tan J and Guo Z: Thrombin promotes fibronectin secretion
by bone marrow mesenchymal stem cells via the protease-activated
receptor mediated signalling pathways. Stem Cell Res Ther.
5:362014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Shiels IA, Ambler JS and Taylor
SM: Pirfenidone reduces fibronectin synthesis by cultured human
retinal pigment epithelial cells. Aust N Z J Ophthalmol. 26 (Suppl
1):S74–S76. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Osusky R, Soriano D, Ye J and Ryan SJ:
Cytokine effect on fibronectin release by retinal pigment
epithelial cells. Curr Eye Res. 13:569–574. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kwon OW, Song JH and Roh MI: Retinal
detachment and proliferative vitreoretinopathy. Dev Ophthalmol.
55:154–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Por ED, Greene WA, Burke TA and Wang HC:
Trichostatin a inhibits retinal pigmented epithelium activation in
an in vitro model of proliferative vitreoretinopathy. J Ocul
Pharmacol Ther. 32:415–524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pennock S, Haddock LJ, Mukai S and
Kazlauskas A: Vascular endothelial growth factor acts primarily via
platelet-derived growth factor recptor α to promote proliferative
vitreoretinopathy. Am J Pathol. 184:3052–3068. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao W, Chen X, Liu X, Luo L, Ye S and Liu
Y: Trichostatin A, a histone deacetylase inhibotor, suppresses
proliferation and epithelial-mesenchymal transition in retinal
pigment epithelial cells. J Cell Mol Med. 18:646–655. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rouberol F and Chiquet C: Proliferative
vitreoretinopathy: Pathophysiology and clinical diagnosis. J Fr
Ophtalmol. 37:557–565. 2014.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Winkler J and Hoerauf H: TGF-β and
RPE-derived cells in taut subretinal strands from patients with
proliferative vitreoretinopathy. Eur J Ophthalmol. 21:422–426.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saika S: TGF beta pathobiology in the eye.
Lab Invest. 86:106–115. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen YS, Hackett SF, Schoenfeld CL,
Vinores MA, Vinores SA and Campochiaro PA: Localisation of vascular
endothelial growth factor and its receptors to cells of vascular
and avascular epiretinal membranes. Br J Ophthalmol. 81:919–926.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bochaton-Piallat ML, Kapetanios AD, Donati
G, Redard M, Gabbiani G and Pournaras CJ: TGF-beta1, TGF-beta
receptor II and ED-A fibronectin expression in myofibroblast of
vitreoretinopathy. Invest Ophthalmol Vis Sci. 41:2336–2342.
2000.PubMed/NCBI
|
|
29
|
Gaudric A, Glacet-Bernard A, Clement G,
Falquerho L, Barritault D and Coscas G: Transforming growth factor
beta in the vitreous of patients with epiretinal proliferation.
Ophthalmologe. 4:51–52. 1990.(In French).
|
|
30
|
Hirase K, Sugiyama T, Ikeda T, Sotozono C,
Yasuhara T, Koizumi K and Kinoshita S: Transforming growth factor
beta (2) increases in subretinal fluid in rhegmatogenous retinal
detachment with subretinal strands. Ophthalmologica. 219:222–225.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cai W, Wei Q, Liu Q, Ren C, Liu J, Zhang
R, He M, Wang Q, Du Y and Yu J: Effect of bradykinin on
TGF-β1-induced retinal pigment epithelial cell proliferation and
extracellular matrix secretion. BMC Ophthalmol. 16:1992016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nassar K and Grisanti S, Tura A, Lüke J,
Lüke M, Soliman M and Grisanti S: A TGF-b receptor 1 inhibitor for
prevention of proliferative vitreoretinopathy. Exp Eye Res.
123:72–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rodrigues-Diez R, Lavoz C, Carvajal G,
Rayego-Mateos S, Rodrigues Diez RR, Ortiz A, Egido J, Mezzano S and
Ruiz-Ortega M: Gremlin is a downstream profibrotic mediator of
transforming growth factor-beta in cultured renal cells. Nephron
Exp Nephrol. 122:62–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma B, Kang Q, Qin L, Cui L and Pei C:
TGF-b2 induces transdifferentiation and fibrosis in human lens
epithelial cells via regulating gremlin and CTGF. Biochem Biophys
Res Commun. 447:689–695. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng H, Zhao X, Guo Q, Feng Y, Ma M, Guo
W, Dong X, Deng C, Li C, Song X, et al: Autophagy resists EMT
progress to maintain retinal pigment epithelium homeostasis. Int J
Biol Sci. 15:507–521. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shanmuganathan S, Sumantran VN and
Angayarkanni N: Epigallocatechin gallate and curcumin prevent
transforming growth factor beta 1-induced epithelial to mesenchymal
transition in ARPE-19 cells. Indian J Med Res. 146 (Suppl
2):S85–S96. 2017. View Article : Google Scholar : PubMed/NCBI
|
